KRM Ayurveda Ltd. (NSE SME)

Language
User profile picture

KRM Ayurveda

January 19, 2026 – January 21, 2026

Price ₹128 - ₹135
GMP Rumors * ₹15
Lot size 1000
Issue size ₹77.49 cr
Allotment Jan 22, 2026
Listing Jan 27, 2026


KRM Ayurveda Lot(s) Distribution

Category Lot(s) Qty Amount Reserved
INDIVIDUAL 2 2000 270000 0
sHNI 3 3000 405000 0
bHNI 8 8000 1080000 0

KRM Ayurveda Reservation

Category Shares Offered %
Total 0 100%

KRM Ayurveda About

IPO Details  As per DRHP
Total Issue Size57,40,000  shares (aggregating up to ₹77.49 Cr)
Fresh Issue57,40,000  shares (aggregating up to ₹77.49 Cr)
Face Value₹10/- Per Share
Issue TypeBookbuilding IPO
Listing AtNSE SME
Share Holding Pre Issue1,55,20,800 shares
Share Holding Post Issue2,12,60,800 shares
IPO Reservation
Investor CategoryShares Offered
QIB Shares OfferedNot more than 50% of the Net Issue
Retail Shares OfferedNot less than 35% of the Net Issue
NII Shares OfferedNot less than 15% of the Net Issue
Key Performance Indicators (KPI)
Details will be added soon.
Company Financial (In ₹Crore) 

Details will be added soon.

About Company

Incorporated on 3 September 2019, KRM Ayurveda Ltd operates a network of Ayurvedic hospitals and clinics across India and has expanded overseas through telemedicine consultations and product sales.

Currently runs 6 hospitals and 5 clinics at multiple locations, providing integrated Ayurvedic healthcare services.

Manufactures Ayurvedic medicines, herbal & botanical remedies, supplements, and wellness / skincare-related products.

Service offerings include hospital-based treatments, clinic consultations, teleconsultation services, and KRM-branded Ayurvedic products.

As of August 31, 2025, the company employs 429 staff across medical, operational, and administrative departments.

IPO proceeds will be utilised for telemedicine facility development (₹13.67 cr), CRM & IT infrastructure (₹1.42 cr), human resources (₹5.44 cr), loan repayment (₹12.50 cr), working capital (₹18.00 cr), and general corporate purposes.

Strength

Qualified Ayurvedic professionals – Skilled physicians and certified therapists ensure consistent treatment quality.

GMP-certified centralized manufacturing – Ensures purity, safety, and efficacy of Ayurvedic medicines.

Trusted brand with repeat clientele – Strong patient loyalty supports recurring revenue and brand equity.

Weakness

Non-ownership of premises – Hospitals and offices are on leased properties; forced relocation could disrupt operations.

Employee attrition risk – Higher attrition among frontline and technical staff may impact service quality and scalability.

Geographical revenue concentration – Majority revenue derived from top two states exposes the company to regional risks.

KRM Ayurveda Lead Manager(s)

KRM Ayurveda Address

KRM Ayurveda Ltd.
Address
A-16
G T Karnal road
North West Delhi, New Delhi, 110033
+91- 9289101700
E-mail: compliance@krmayurveda.com
Website: https://www.krmayurvedaindia.com/

KRM Ayurveda Registrar

Skyline Financial Services Private Ltd
Address: Skyline Financial Services Private Ltd D-153A, 1st Floor, Okhla Industrial Area, Phase-I, New Delhi -110020